Since EGF-receptor stimulates proliferation via MAP-kinases (Figure 6A), which has been established as therapeutic target in the treatment of advanced CRC, we investigated the protein expression and activation patterns of EGFR and downstream activated kinases AKT and p42/44 MAPK. The gene discussed is AKT1; the disease is colorectal carcinoma.